VERU vs VRCA

Veru Inc. vs Verrica Pharmaceuticals Inc. — Valuation Comparison 2026

VERU

Pharmaceutical Preparations
Veru Inc.
Quality
4.6
out of 10
Value Trap
25
LOW
Price
$2.37
Last close
Models
7/13
Active
VS

VRCA

Pharmaceutical Preparations
Verrica Pharmaceuticals Inc.
Quality
5.4
out of 10
Value Trap
30
LOW
Price
$5.76
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType VERU Fair ValueVERU Upside VRCA Fair ValueVRCA Upside
Bayesian DCF Intrinsic $1.44 -39.1% $1.88 -67.4%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $3.71 +56.7% $2.61 -54.7%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for VERU vs VRCA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

VERU vs VRCA — Which Stock Is More Undervalued?

VRCA scores higher with a 5.4/10 quality rating vs VERU's 4.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Veru Inc. (VERU) and Verrica Pharmaceuticals Inc. (VRCA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

VERU currently trades at $2.37 with a QOC of 4.6/10, while VRCA trades at $5.76 with a QOC of 5.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).